Michael D. Hooven, Director at AtriCure, Inc. (ATRC), bought 1,045 shares at $7.65 ($8K) on 2012-09-14, disclosed to the SEC on 2012-09-17.
Open-market purchase of $8k ATRC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.65 | 500 | $4K | 47.6% |
| 2 | $7.67 | 200 | $2K | 19.1% |
| 3 | $7.73 | 5 | $39 | 0.5% |
| 4 | $7.75 | 340 | $3K | 32.8% |
| Total | $7.69 avg | 1,045 | $8K | 100% |
| Filing → |
| ATRC | SELL | 2015-04-01 | $1.5M | — | Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-14 | $8K | — | Filing → |